J. Crandall
Aging · with Barzilai · 2016
A researcher in the Science corpus: 1 paper; trusts 4 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Aging — 9 citations into it
- Molecular Biology — 8 citations into it
- Physiology — 8 citations into it
Whom J. Crandall trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from J. Crandall's perspective
Ordered by how strongly the researchers J. Crandall trusts endorse each paper. Same corpus, a different order for every researcher.
- Rapamycin fed late in life extends lifespan in genetically heterogeneous mice (Nature)
- Metformin Induces a Dietary Restriction–Like State and the Oxidative Stress Response to Extend C. elegans Healthspan via AMPK, LKB1, and SKN-1 (PLoS ONE)
- mTOR is a key modulator of ageing and age-related disease (Nature)
- New Users of Metformin Are at Low Risk of Incident Cancer (Diabetes Care)
- Metformin Retards Aging in C. elegans by Altering Microbial Folate and Methionine Metabolism (Cell)
- Metformin improves healthspan and lifespan in mice (Nature Communications)
- Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. (The journals of gerontology. Series A, Biological sciences and medical sciences)
- Promoting Health and Longevity through Diet: from Model Organisms to Humans (Cell)
- Genetics: Influence of TOR kinase on lifespan in C. elegans (Nature)
- Regulation of Yeast Replicative Life Span by TOR and Sch9 in Response to Nutrients (Science)
Their papers
- Metformin as a Tool to Target Aging (2016) — 967 citations